the me31b dead-box helicase localizes to postsynaptic foci and
mir-34a regulates therapy resistance by targeting
parp inhibitor veliparib and hdac inhibitor saha s
5 è2ax/53bp1 foci formation and loss (dsb repair dynamics)
topoisomerase iiβ mediates the resistance of gliob